• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal and Metabolic Medicine
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality Assessment
      • Environmental, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • People and Culture
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/From Our Labs

Science pic: Riding the bronchosphere

By
Eric Bender
Apr 30, 2015

bronchosphere tissue model
Image by Aron Jaffe of Novartis, first published in Cell Reports

Not to put too fine a point on this, asthma and cystic fibrosis are diseases of mucus—too much mucus, which fills small airways in the lungs and makes it hard to breathe. The flood of mucus comes from bad life choices by basal cells, parent cells that can produce either “goblet” cells (the mucus makers) or ciliated cells (whose tiny hair-like protrusions wave the mucus along the airways). In these diseases, too many goblet cells and too few ciliated cells are produced. So what can persuade the basal cells to make more balanced decisions?

Aron Jaffe of Developmental & Molecular Pathways at the Novartis Institutes for BioMedical Research (NIBR) in Cambridge and his colleagues began to address this question by culturing human basal cells in three dimensions to create “bronchosphere” tissue models.

“This is the first human cell culture that has all three cells: the progenitor basal cells, ciliated cells and goblet cells,” Jaffe says. “We also scaled the system up to 384-well plates, which is probably the big technical hurdle for doing unbiased drug screening.”

In early work with their bronchosphere models, Jaffe and coworkers discovered that inhibiting a protein called Notch2 shifts the balance of cell production back toward ciliated cells, raising the potential of novel treatments for asthma and cystic fibrosis.

Here, in this image of a slice through a healthy bronchosphere taken by confocal microscopy, DNA is shown in blue. Markers for basal cells appear in red, for goblet cells in green, and for ciliated cells in orange.

Learn more about the bronchosphere model in “Asthma researchers muck out mucus cells.”

Tags: 
Biomedical Research, Drug Discovery, Novartis Institutes for BioMedical Research, Scientific Research, Biomedical Science

Eric Bender

Eric Bender

has written about science ranging in scale from RNA to the outer heliosphere. During his spare time, he messes about in boats (in the summer) and shovels (in the winter).

    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

Coronavirus
From Our Labs

A visual tour of scientific strategies for combating coronavirus

Wendi Yajnik, Global Head of Academic Partnerships and External Innovation for research
From Our Labs

Advancing medicine through collaboration

Special instrument controlled by a production associate
From Our Labs

Turning the power of nuclear technology into a medical force

You are here

  1. Home ›
  2. Stories ›
  3. From Our Labs

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.